Clinical Trial Update: Study of Single and Multiple Ascending Doses of ZE46-0134 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation study of ZE46-0134 in healthy volunteers has completed, with acute myeloid leukemia listed as the related condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• ZE46-0134

Snippet

Sponsor: Lomond Therapeutics Holdings, Inc. | Conditions: AML | Phase 1 | Status: COMPLETED